Spinal Cord Stimulation Fails to Improve Mobility in Advanced Parkinson’s Patients
Despite being safe, spinal cord stimulation does not lead to significant improvements in mobility in patients with advanced…
Joana holds a bachelor’s in biology, a Master of Science in evolutionary and developmental biology, and a PhD in biomedical sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — those that make up the lining of blood vessels — found in the umbilical cord of newborns. In addition to several research fellowships, she was awarded two Erasmus scholarships to conduct part of her studies in France.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Despite being safe, spinal cord stimulation does not lead to significant improvements in mobility in patients with advanced…
Scientists have created a device that allows them to accurately measure the levels of different pro-inflammatory cytokines — molecules…
Use of duloxetine, a treatment for depression and nerve pain, fails to alleviate pain in people with Parkinson’s…
Mutations in a gene called ATP10B may increase the risk of developing Parkinson’s…
Scientists have discovered a series of rare variants in genes that control the function of lysosomes — cell compartments…
A probiotic strain of the bacteria Bacillus subtilis called PXN21 can prevent the buildup of the protein alpha-synuclein…
Despite being safe and well-tolerated, foliglurax (PTX002331), an investigational therapy for Parkinson’s disease, failed to significantly reduce some…
Activated immune T-cells can infiltrate the brain and promote neurodegeneration in non-human primate models of Parkinson’s during the chronic stages…
A potential oral therapy for Parkinson’s disease and amyotrophic lateral sclerosis (ALS) was seen to be…
Tasigna (nilotinib), an approved leukemia medication being tested as a repurposed treatment for Parkinson’s disease, was found to…
Get regular updates to your inbox.